Spiro Rombotis
2009
In 2009, Spiro Rombotis earned a total compensation of $630.2K as President and Chief Executive Officer at Cyclacel Pharmaceuticals.
Compensation breakdown
| Bonus | $138,000 |
|---|---|
| Salary | $460,000 |
| Other | $32,188 |
| Total | $630,188 |
Rombotis received $460K in salary, accounting for 73% of the total pay in 2009.
Rombotis also received $138K in bonus and $32.2K in other compensation.
Rankings
In 2009, Spiro Rombotis' compensation ranked 6,050th out of 9,885 executives tracked by ExecPay. In other words, Rombotis earned more than 38.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,050 out of 9,885 | 39th |
Division Manufacturing | 2,188 out of 3,690 | 41st |
Major group Chemicals And Allied Products | 467 out of 866 | 46th |
Industry group Drugs | 311 out of 638 | 51st |
Industry Pharmaceutical Preparations | 227 out of 446 | 49th |
Source: SEC filing on April 26, 2011.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2009.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020